Endothelial cell infection and endotheliitis in COVID-19

Cardiovascular complications are rapidly emerging as a key threat in
coronavirus disease 2019 (COVID-19) in addition to respiratory disease.
The mechanisms underlying the disproportionate effect of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on patients with cardiovascular comorbidities, however, remain incompletely understood.

Endothelial cell infection and endotheliitis in COVID-19
Size: 405 KB